Certified by Founder Lodge
Maxion Therapeutics
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $16,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 21 ,2023 | Series A | $16,000,000 | |
| March, 18 ,2025 | Series A | $72,000,000.00 | |
| March, 18 ,2025 | Series A | $72,000,000.00 |
BGF
LifeArc Ventures
Monograph Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Stratus Medical | $10,000,000 | (Feb 5, 2026)
beHuman Corp. | $4,000,000 | (Feb 5, 2026)
Positron AI | $230,000,000 | (Feb 5, 2026)
Boomband | $4,000,000 | (Feb 5, 2026)
Expert Intelligence⢠| $4,700,000 | (Feb 5, 2026)